Citi Reiterates a 'Speculative Buy' Rating on Brightpoint (CELL); Singapore Headwinds, but Overall Trends Moving in the Right Direction

August 6, 2010 11:42 AM EDT Send to a Friend
Citi reiterates a 'Speculative Buy' rating on Brightpoint (Nasdaq: CELL), price target $10.

Citi analyst says, "Reduce target to $10 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login